stockrowInteger Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) Shares outstanding
Integer Holdings Corporation's shares outstanding at the end of fiscal 2025 was $35.6M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $34.6M. Over the past ten years it has ranged from $26.4M (fiscal 2015) to $35.6M (fiscal 2024); the current reading is higher than 91% of that period. Integer Holdings Corporation ranks 80th of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $35.6M | (0.15%) |
| FY2024 | $35.6M | 5.60% |
| FY2023 | $33.8M | 1.20% |
| FY2022 | $33.4M | 0.30% |
| FY2021 | $33.3M | 0.44% |
| FY2020 | $33.1M | 0.23% |
| FY2019 | $33.0M | 1.35% |
| FY2018 | $32.6M | 1.68% |
| FY2017 | $32.1M | 3.50% |
| FY2016 | $31.0M | 17.49% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $34.6M | 1.34% |
| Jun 2026 | $34.1M | (0.84%) |
| Mar 2026 | $34.4M | (3.26%) |
| Dec 2025 | $35.6M | (0.04%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| NEOG Neogen Corporation compare | $218.1M |
| TXG 10x Genomics compare | $130.0M |
| AXGN AxoGen, Inc. compare | $61.5M |
| LIVN LivaNova PLC compare | $57.4M |
| HAE Haemonetics Corporation compare | $46.5M |
| TMDX TransMedics Group, Inc. compare | $40.8M |
| ITGR Integer Holdings Corporation | $34.6M |
| IRTC iRhythm Holdings, Inc. compare | $33.1M |
| UFPT UFP Technologies, Inc. compare | $7.8M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement